by John Finey | Oct 10, 2016 | Blog, Brexit
I might be an old cynic but I fear that both the challenges and the opportunities presented by Brexit will lead more people to consider what I am going to call ‘more creative business practices’. To misquote a colleague’s favourite saying, “there are two things...
by John Finey | Oct 10, 2016 | Blog, Brexit
With the Pound in freefall, I am sure we have all done a quick calculation to try to second guess how it will affect us. The most obvious is the cost of holidaying abroad; next summer’s trip to France will cost considerably more in terms of travel and accommodation...
by John Finey | Feb 15, 2016 | Blog
The saying goes ‘you learn something new every day’ and it’s also true that this can happen at the strangest time and in the weirdest place. An example would in the Gents at a 50th birthday party late one Saturday night! I am sure all possibilities spring to mind but...
by John Finey | Feb 15, 2016 | Blog
Big news of the week of course is the publishing of the Delegated Regulation that supplements the Falsified Medicines Directive and enables the industry to take the next steps in protecting the public against the menace of falsified medicines. There will be much...
by John Finey | Jun 4, 2015 | Behind the scenes, Blog, Business, Consultancy, EudraGMDP, GDP/RP, Good Distribution Practice - GDP, Licence Acquisition, MHRA, pharmacy business development, Pharmacy Suppliers, Quality Systems, Regulation, Training, WDA(H), WDA(H)
For pretty much the whole of the last six months the team at PCL have been trying to make headway with certain issues thrown up by the EU Guidelines on GDP for Medicinal Products for Human Use (5th Nov 2013). On face value it is hugely helpful that there are common...
